dr. o'neil discusses napabucasin with folfiri and bevacizumab in crc
Published 7 years ago • 238 plays • Length 1:37Download video MP4
Download video MP3
Similar videos
-
0:56
dr. o'neil on next steps for napabucasin with folfiri and bevacizumab in crc
-
9:07
tribe-2: folfox or folfiri with bevacizumab in mcrc
-
2:00
dr. mizrahi on bevacizumab as a chemoprotectant in crc
-
1:00
dr. muro discusses safety data from asian xeliri project in crc
-
0:54
dr. o'neil on stemness inhibitors for crc treatment
-
0:58
dr. saab on napabucasin (bbi-608) in colorectal cancer treatment
-
1:38
dr. bekaii-saab on napabucasin in patients with pancreatic cancer
-
2:42
dr. bekaii-saab discusses an analysis of bevacizumab or cetuximab for crc
-
4:56
upfront bevacizumab and cetuximab compared in metastatic colorectal cancer
-
0:51
dr. saltz discusses folfirinox in colorectal cancer
-
1:18
dr. joel neal on impact of pd-l1 tests on pembrolizumab, nivolumab efficacy in frontline nsclc
-
1:08
what is a colon polyp?
-
0:38
copy of dr. nelson on novel combination therapies in colorectal cancer
-
1:30
dr. bekaii-saab on napabucasin plus nab-paclitaxel in pancreatic cancer
-
1:29
dr. cremolini on folfoxiri plus bevacizumab for metastatic colorectal cancer
-
1:13
dr. bekaii-saab on the potential impact of napabucasin combo in pancreatic cancer
-
2:01
dr. saab on napabucasin with gemcitabine and nab-paclitaxel in pancreatic adenocarcinoma
-
5:48
bevacizumab use in angiogenesis clinical practice
-
2:35
dr. sharlene gill discusses adding napabucasin to gemcitabine/nab-paclitaxel therapy in mpdac